1
|
Xia L, Wang H, Du G, Cheng X, Zhang R, Yu H, Cheng M, Chen Y, Qin S, Leng W. Receptor accessory protein 6, a novel ferroptosis suppressor, drives oral squamous cell carcinoma by maintaining endoplasmic reticulum hemostasis. Int J Biol Macromol 2024; 283:137565. [PMID: 39566754 DOI: 10.1016/j.ijbiomac.2024.137565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2024] [Revised: 11/09/2024] [Accepted: 11/10/2024] [Indexed: 11/22/2024]
Abstract
Increasing evidence suggests a close association between endoplasmic-reticulum (ER) stress and ferroptosis. Receptor accessory protein 6 (REEP6) is known to play a crucial role in maintaining ER homeostasis. However, its involvement in ferroptosis remains unknown. In this study, we found that REEP6 was overexpressed, and its overexpression showed a significant association with tumor size and poor survival in OSCC patients. Besides, in vitro and in vivo assays together showed that REEP6 plays an oncogenic role in OSCC progression. The GO/KEGG, and GSEA analysis showed that REEP6 overexpression leads to the inactivation of ferroptosis signaling in OSCC. Moreover, REEP6 overexpression conferred resistance to RSL3, a ferroptosis inducer, whereas REEP6 knockdown sensitized OSCC cells to RSL3. Overexpression of REEP6 decrease the accumulation of iron ions, ROS production, but increase the number of mitochondrial cristae in OSCC cells. More importantly, we confirmed that REEP6 inhibited ferroptosis in OSCC cells by maintaining ER homeostasis via regulating ACSL4 expression. In addition, we identified promoter DNA hypomethylation as the underlying cause of REEP6 overexpression in OSCC. Taken together, REEP6 acts as a novel suppressor of ferroptosis, with its overexpression driven by promoter hypomethylation contributing to OSCC progression by ER stress-mediated ferroptosis via ACSL4.
Collapse
Affiliation(s)
- Lingyun Xia
- Department of Stomatology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China; Institute of Oral Diseases, School of Dentistry, Hubei University of Medicine, Shiyan 442000, China
| | - Hongbing Wang
- Department of Stomatology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China; Institute of Oral Diseases, School of Dentistry, Hubei University of Medicine, Shiyan 442000, China
| | - Gao Du
- Department of Stomatology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China; Institute of Oral Diseases, School of Dentistry, Hubei University of Medicine, Shiyan 442000, China
| | - Xiaobo Cheng
- Department of Stomatology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China; Institute of Oral Diseases, School of Dentistry, Hubei University of Medicine, Shiyan 442000, China
| | - Rui Zhang
- Department of Stomatology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China; Institute of Oral Diseases, School of Dentistry, Hubei University of Medicine, Shiyan 442000, China
| | - Hedong Yu
- Department of Stomatology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China; Institute of Oral Diseases, School of Dentistry, Hubei University of Medicine, Shiyan 442000, China
| | - Mumo Cheng
- Department of General Practice, Shanghai Baoshan District Wusong Central Hospital (Zhongshan Hospital Wusong Branch, Fudan University), Shanghai 200940, China
| | - Yongji Chen
- Department of Stomatology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China; Institute of Oral Diseases, School of Dentistry, Hubei University of Medicine, Shiyan 442000, China.
| | - Shanshan Qin
- Department of Stomatology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China; Institute of Oral Diseases, School of Dentistry, Hubei University of Medicine, Shiyan 442000, China.
| | - Weidong Leng
- Department of Stomatology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China; Institute of Oral Diseases, School of Dentistry, Hubei University of Medicine, Shiyan 442000, China.
| |
Collapse
|
2
|
Netherton JK, Ogle RA, Robinson BR, Molloy M, Krisp C, Velkov T, Casagranda F, Dominado N, Silva Balbin Villaverde AI, Zhang XD, Hime GR, Baker MA. The role of HnrnpF/H as a driver of oligoteratozoospermia. iScience 2024; 27:110198. [PMID: 39092172 PMCID: PMC11292545 DOI: 10.1016/j.isci.2024.110198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2023] [Revised: 02/20/2024] [Accepted: 06/03/2024] [Indexed: 08/04/2024] Open
Abstract
Male subfertility or infertility is a common condition often characterized by men producing a low number of sperm with poor quality. To gain insight into this condition, we performed a quantitative proteomic analysis of semen samples obtained from infertile and fertile men. At least 6 proteins showed significant differences in regulation of alternatively spliced isoforms. To investigate this link between aberrant alternative splicing and production of poor-quality spermatozoa, we overexpressed the hnrnpH/F-orthologue Glorund (Glo) in Drosophila, which was also found to be abundant in poor quality human sperm. Transgenic animals produced low numbers of morphologically defective spermatozoa and aberrant formation of the "dense body," an organelle akin to the mammalian manchette. Furthermore, fertility trials demonstrated that transgenic flies were either completely infertile or highly subfertile. These findings suggest that dysregulation of hnrnpH/F is likely to result in the production of low-quality semen, leading to subfertility or infertility in men.
Collapse
Affiliation(s)
- Jacob K. Netherton
- School of Biomedical Sciences and Pharmacy, Faculty of Medicine and Health, University of Newcastle, Callaghan, NSW 2308, Australia
| | - Rachel A. Ogle
- School of Biomedical Sciences and Pharmacy, Faculty of Medicine and Health, University of Newcastle, Callaghan, NSW 2308, Australia
| | - Benjamin R. Robinson
- School of Biomedical Sciences and Pharmacy, Faculty of Medicine and Health, University of Newcastle, Callaghan, NSW 2308, Australia
| | - Mark Molloy
- Australian Proteome Analysis Facility, Department of Biomolecular Sciences, Macquarie University, NSW 2109 Australia
| | - Christoph Krisp
- Australian Proteome Analysis Facility, Department of Biomolecular Sciences, Macquarie University, NSW 2109 Australia
| | - Tony Velkov
- Biomedicine Discovery Institute, Infection & Immunity Program and Department of Microbiology, Monash University, Clayton, VIC 3168, Australia
| | - Franca Casagranda
- Department of Anatomy and Physiology, University of Melbourne, Parkville, VIC 3010, Australia
| | - Nicole Dominado
- Department of Anatomy and Physiology, University of Melbourne, Parkville, VIC 3010, Australia
| | | | - Xu Dong Zhang
- School of Biomedical Sciences and Pharmacy, Faculty of Medicine and Health, University of Newcastle, Callaghan, NSW 2308, Australia
| | - Gary R. Hime
- Department of Anatomy and Physiology, University of Melbourne, Parkville, VIC 3010, Australia
| | - Mark A. Baker
- School of Biomedical Sciences and Pharmacy, Faculty of Medicine and Health, University of Newcastle, Callaghan, NSW 2308, Australia
| |
Collapse
|
3
|
Shkrigunov T, Zgoda V, Klimenko P, Kozlova A, Klimenko M, Lisitsa A, Kurtser M, Petushkova N. The Application of Ejaculate-Based Shotgun Proteomics for Male Infertility Screening. Biomedicines 2023; 12:49. [PMID: 38255156 PMCID: PMC10813512 DOI: 10.3390/biomedicines12010049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2023] [Revised: 12/13/2023] [Accepted: 12/16/2023] [Indexed: 01/24/2024] Open
Abstract
Problems with the male reproductive system are of both medical and social significance. As a rule, spermatozoa and seminal plasma proteomes are investigated separately to assess sperm quality. The current study aimed to compare ejaculate proteomes with spermatozoa and seminal plasma protein profiles regarding the identification of proteins related to fertility scores. A total of 1779, 715, and 2163 proteins were identified in the ejaculate, seminal plasma, and spermatozoa, respectively. Among these datasets, 472 proteins were shared. GO enrichment analysis of the common proteins enabled us to distinguish biological processes such as single fertilization (GO:0007338), spermatid development (GO:0007286), and cell motility (GO:0048870). Among the abundant terms for GO cellular components, zona pellucida receptor complex, sperm fibrous sheath, and outer dense fiber were revealed. Overall, we identified 139 testis-specific proteins. For these proteins, PPI networks that are common in ejaculate, spermatozoa, and seminal plasma were related to the following GO biological processes: cilium movement (GO:0003341), microtubule-based movement (GO:0007018), and sperm motility (GO:0097722). For ejaculate and spermatozoa, they shared 15 common testis-specific proteins with spermatogenesis (GO:0007283) and male gamete generation (GO:0048232). Therefore, we speculated that ejaculate-based proteomics could yield new insights into the peculiar reproductive physiology and spermatozoa function of men and potentially serve as an explanation for male infertility screening.
Collapse
Affiliation(s)
- Timur Shkrigunov
- Laboratory of Protein Biochemistry and Pathology, Institute of Biomedical Chemistry, 119121 Moscow, Russia; (A.L.); (N.P.)
| | - Victor Zgoda
- Laboratory of Systems Biology, Institute of Biomedical Chemistry, 119121 Moscow, Russia;
| | - Peter Klimenko
- Department of Obstetrics and Gynecology, Pirogov Russian National Research Medical University, 117997 Moscow, Russia; (P.K.); (M.K.)
| | - Anna Kozlova
- Center of Scientific and Practical Education, Institute of Biomedical Chemistry, 119121 Moscow, Russia;
| | - Maria Klimenko
- Center for Family Planning and Reproduction, Moscow Department of Health, 117209 Moscow, Russia;
| | - Andrey Lisitsa
- Laboratory of Protein Biochemistry and Pathology, Institute of Biomedical Chemistry, 119121 Moscow, Russia; (A.L.); (N.P.)
- Center of Scientific and Practical Education, Institute of Biomedical Chemistry, 119121 Moscow, Russia;
| | - Mark Kurtser
- Department of Obstetrics and Gynecology, Pirogov Russian National Research Medical University, 117997 Moscow, Russia; (P.K.); (M.K.)
| | - Natalia Petushkova
- Laboratory of Protein Biochemistry and Pathology, Institute of Biomedical Chemistry, 119121 Moscow, Russia; (A.L.); (N.P.)
| |
Collapse
|